The influence of adjuvant therapy on cardiorespiratory fitness in early-stage breast cancer seven years after diagnosis: The Cooper Center Longitudinal Study

Breast Cancer Research and Treatment

Volumn 138, Issue 3, 2013, Pages 909-916

  Lakoski, Susan G ^a   Barlow, Carolyn E ^b   Koelwyn, Graeme J ^c   Hornsby, Whitney E ^d   Hernandez, Jesse ^b   Defina, Laura F ^b   Radford, Nina B ^b   Thomas, Samantha M ^d   Herndon II, James E ^d   Peppercorn, Jeffrey ^d   Douglas, Pamela S ^d   Jones, Lee W ^d  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b Cooper Institute ^*  (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d DUKE UNIVERSITY   (United States)

Author keywords

Adjuvant therapy; Breast cancer; Cardiorespiratory fitness; Cardiovascular risk

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER SURVIVOR; CARDIORESPIRATORY FITNESS; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST; EARLY CANCER; EXERCISE; EXERCISE TOLERANCE TEST; EXHAUSTION; FEMALE; FITNESS; GENDER; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; METABOLISM; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARDIOVASCULAR PHYSIOLOGICAL PHENOMENA; CASE-CONTROL STUDIES; COMBINED MODALITY THERAPY; EXERCISE TEST; EXERCISE TOLERANCE; FATIGUE; FEMALE; HUMANS; LONGITUDINAL STUDIES; MASTECTOMY; MIDDLE AGED; PHYSICAL FITNESS; PROSPECTIVE STUDIES; SURVIVORS;

EID: 84877805674     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-013-2478-1     Document Type: Article

References (25)

1. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62(1):10-29
2. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ (2006) Cancer statistics, 2006. CA Cancer J Clin 56(2):106-130
3. Jones LW, Haykowsky MJ, Swartz JJ, Douglas PS, Mackey JR (2007) Early breast cancer therapy and cardiovascular injury. J Am Coll Cardiol 50(15):1435-1441
4. Lakoski SG, Eves ND, Douglas PS, Jones LW (2012) Exercise rehabilitation in patients with cancer. Nat Rev Clin Oncol 9(5):288-296
5. Ewer MS, Lippman SM (2005) Type II chemotherapy-related cardiac dysfunction: time to recognize a new entity. J Clin Oncol Off J Am Soc Clin Oncol 23(13):2900-2902
6. Jannazzo A, Hoffman J, Lutz M (2008) Monitoring of anthracycline-induced cardiotoxicity. Ann Pharmacother 42(1):99-104
7. Hsia CC, Ramanathan M, Estrera AS (1992) Recruitment of diffusing capacity with exercise in patients after pneumonectomy. Am Rev Respir Dis 145(4 Pt 1):811-816
8. Jones LW, Eves ND, Haykowsky M, Joy AA, Douglas PS (2008) Cardiorespiratory exercise testing in clinical oncology research: systematic review and practice recommendations. Lancet Oncol 9(8):757-765
9. Gupta S, Rohatgi A, Ayers CR, Willis BL, Haskell WL, Khera A, Drazner MH, de Lemos JA, Berry JD (2011) Cardiorespiratory fitness and classification of risk of cardiovascular disease mortality. Circulation 123(13):1377-1383
10. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE (2002) Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 346(11):793-801
11. Blair SN, Kohl HW III, Paffenbarger RS Jr, Clark DG, Cooper KH, Gibbons LW (1989) Physical fitness and all-cause mortality. A prospective study of healthy men and women. JAMA 262(17):2395-2401
12. Blair SN, Kohl HW III, Barlow CE, Paffenbarger RS Jr, Gibbons LW, Macera CA (1995) Changes in physical fitness and all-cause mortality. A prospective study of healthy and unhealthy men. JAMA 273(14):1093-1098
13. Lakoski SG, Barlow CE, Farrell SW, Berry JD, Morrow JR Jr, Haskell WL (2011) Impact of body mass index, physical activity, and other clinical factors on cardiorespiratory fitness (from the Cooper Center Longitudinal Study). Am J Cardiol 108(1):34-39
14. Pollock ML, Foster C, Schmidt D, Hellman C, Linnerud AC, Ward A (1982) Comparative analysis of physiologic responses to three different maximal graded exercise test protocols in healthy women. Am Heart J 103(3):363-373
15. Pollock ML, Bohannon RL, Cooper KH, Ayres JJ, Ward A, White SR, Linnerud AC (1976) A comparative analysis of four protocols for maximal treadmill stress testing. Am Heart J 92(1):39-46
16. Ho JS, Fitzgerald SJ, Barlow CE, Cannaday JJ, Kohl HW III, Haskell WL, Cooper KH (2010) Risk of mortality increases with increasing number of abnormal non-ST parameters recorded during exercise testing. Eur J Cardiovasc Prev Rehabil Off J Eur Soc Cardiol Work Groups Epidemiol Prev Cardiac Rehabil Exerc Physiol 17(4):462-468
17. Peel JB, Sui X, Adams SA, Hebert JR, Hardin JW, Blair SN (2009) A prospective study of cardiorespiratory fitness and breast cancer mortality. Med Sci Sports Exerc 41(4):742-748
18. Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ, O'Brien WL, Bassett DR Jr, Schmitz KH, Emplaincourt PO et al (2000) Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 32(9 Suppl):S498-S504
19. Jones LW, Courneya KS, Mackey JR, Muss H, Pituskin EN, Scott JM, Hornsby WE, Coan AD, Herndon JE II, Douglas PS et al (2012) Cardiopulmonary function and age-related decline across the breast cancer survivorship continuum. J Clin Oncol 30(20):2530-2537
20. Froelicher VF Jr, Thompson AJ Jr, Davis G, Stewart AJ, Triebwasser JH (1975) Prediction of maximal oxygen consumption. Comparison of the Bruce and Balke treadmill protocols. Chest 68(3):331-336
21. Hermansen L, Saltin B (1969) Oxygen uptake during maximal treadmill and bicycle exercise. J Appl Physiol 26(1):31-37
22. Khakoo AY, Yeh ET (2008) Therapy insight: management of cardiovascular disease in patients with cancer and cardiac complications of cancer therapy. Nat Clin Pract Oncol 5(11):655-667
23. Darby SC, Cutter DJ, Boerma M, Constine LS, Fajardo LF, Kodama K, Mabuchi K, Marks LB, Mettler FA, Pierce LJ et al (2010) Radiation-related heart disease: current knowledge and future prospects. Int J Radiat Oncol Biol Phys 76(3):656-665
24. Yeh ET, Tong AT, Lenihan DJ, Yusuf SW, Swafford J, Champion C, Durand JB, Gibbs H, Zafarmand AA, Ewer MS (2004) Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management. Circulation 109(25):3122-3131
25. Hudson MM, Ness KK, Nolan VG, Armstrong GT, Green DM, Morris EB, Spunt SL, Metzger ML, Krull KR, Klosky JL et al (2011) Prospective medical assessment of adults surviving childhood cancer: study design, cohort characteristics, and feasibility of the St. Jude Lifetime Cohort Study. Pediatr Blood Cancer 56(5):825-836